PTOTSLPPilotJournal of neuroengineering and rehabilitation2016

Global cognitive function and processing speed are associated with gait and balance dysfunction in Parkinson's disease.

Gian Pal, Joan O'Keefe, Erin Robertson-Dick and 3 others

PMID 27793167

WHAT IT FOUND

In 14 people with Parkinson's, lower global cognitive scores correlated with slower walking and more sway.

Processing speed specifically linked to turning difficulty. No control group and tiny sample mean these associations are hypotheses, not evidence of cause.

Key findings

01Global cognitive function (MDRS) correlated strongly with stride velocity, turn duration, and number of steps to turn.

02Processing speed was the only specific cognitive domain significantly associated with gait turning measures after correction.

03No significant correlation was found between global cognitive scores and the clinical PIGD score.

STILL TO COME

How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

Very small sample size (n=14) limits generalizability and statistical power. No healthy control group, so it is unclear if these relationships are specific to Parkinson's or also present in normal aging. Only one neuropsychological test was used per cognitive domain. Cross-sectional design cannot determine whether cognitive deficits cause gait issues or vice versa. Participants were in the ON medication state, so results may not apply to the OFF state.

Declared interests

The paper states it is a pilot project using commercially available APDM Mobility Lab. No specific funding sources or conflicts of interest are declared in the provided text.

The easy way to misread this

Do not assume that improving processing speed will improve gait. This study shows a correlation in a very small group, not a causal link. The lack of a control group means we do not know if these relationships are unique to Parkinson's disease.

Read it on PubMed →